Brett Sandercock is CFO at RESMED INC (RMD). They have made 105 open-market trades across 1 company since 2006, most recently 2026-04-01.
CIK 0001346064
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 105 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RMD | 83,495 | $20.0M |
Shares reported on the most recent Form 4, priced at the 2026-04-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RMD | SELL · 10b5-1 | 2026-04-01 | 2026-04-03 | $224.31 | $224K | +2.0% | -6.7% | -6.5% |
| RMD | SELL · 10b5-1 | 2026-03-02 | 2026-03-03 | $254.30 | $254K | -11.2% | -13.8% | -28.3% |
| RMD | SELL · 10b5-1 | 2026-02-02 | 2026-02-03 | $257.03 | $257K | +0.5% | +1.6% | -16.8% |
| RMD | SELL · 10b5-1 | 2026-01-02 | 2026-01-05 | $241.75 | $242K | +6.5% | +7.5% | -8.1% |
| RMD | SELL · 10b5-1 | 2025-12-01 | 2025-12-02 | $244.16 | $244K | +0.3% | -2.6% | +2.4% |
| RMD | SELL · 10b5-1 | 2025-11-03 | 2025-11-04 | $247.54 | $743K | -0.3% | +2.5% | +3.8% |
| RMD | SELL · 10b5-1 | 2025-10-01 | 2025-10-03 | $274.36 | $823K | -3.5% | -10.9% | -12.4% |
| RMD | SELL · 10b5-1 | 2025-09-02 | 2025-09-03 | $270.77 | $812K | +0.3% | +3.1% | -7.2% |
| RMD | SELL · 10b5-1 | 2025-08-01 | 2025-08-05 | $281.90 | $1.7M | +0.1% | -3.8% | -12.5% |
| RMD | SELL · 10b5-1 | 2025-07-01 | 2025-07-02 | $256.99 | $2.0M | -1.5% | +9.1% | +7.0% |
| RMD | SELL · 10b5-1 | 2025-06-02 | 2025-06-03 | $243.78 | $244K | +0.8% | +3.9% | +9.6% |
| RMD | SELL · 10b5-1 | 2025-05-22 | 2025-05-27 | $244.59 | $1.8M | +2.6% | +4.2% | +16.3% |
| RMD | SELL · 10b5-1 | 2025-04-08 | 2025-04-10 | $215.58 | $216K | +1.1% | +16.7% | +20.7% |
| RMD | SELL · 10b5-1 | 2025-03-10 | 2025-03-11 | $230.36 | $230K | -1.5% | -5.6% | +12.6% |
| RMD | SELL · 10b5-1 | 2025-02-10 | 2025-02-11 | $238.98 | $239K | -2.8% | -7.0% | +4.8% |
| RMD | SELL · 10b5-1 | 2025-01-08 | 2025-01-10 | $234.04 | $234K | +7.5% | +3.0% | -9.1% |
| RMD | SELL · 10b5-1 | 2024-12-09 | 2024-12-11 | $244.23 | $244K | -4.9% | -3.8% | -7.1% |
| RMD | SELL · 10b5-1 | 2024-11-08 | 2024-11-12 | $249.00 | $249K | -1.1% | -1.6% | -3.2% |
| RMD | SELL · 10b5-1 | 2024-10-08 | 2024-10-09 | $233.47 | $233K | +2.7% | +8.0% | +1.1% |
| RMD | SELL · 10b5-1 | 2024-09-09 | 2024-09-10 | $246.42 | $246K | -2.5% | -5.3% | -2.6% |
| RMD | SELL · 10b5-1 | 2024-08-08 | 2024-08-12 | $212.16 | $212K | +3.2% | +16.8% | +14.8% |
| RMD | SELL · 10b5-1 | 2024-07-08 | 2024-07-09 | $194.35 | $194K | +6.0% | +11.7% | +21.1% |
| RMD | SELL · 10b5-1 | 2024-06-10 | 2024-06-11 | $209.81 | $210K | -14.0% | -5.7% | +17.8% |
| RMD | SELL · 10b5-1 | 2024-05-08 | 2024-05-10 | $211.37 | $2.7M | +1.5% | -1.6% | -0.4% |
| RMD | SELL | 2023-11-27 | 2023-11-29 | $152.62 | $458K | +2.7% | +8.0% | +13.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.